Become China's Leading SMO Service Platform in 10 Years

A wholly-owned subsidiary of Tigermed, Simo established in May 2011. So far, we have a professional team of more than 3,600 people, serving more than 1,100 trial sites in 140 cities across China. We are committed to improving the quality and progress of clinical trials and promoting the standardization of clinical trials by providing professional SMO services to assist sites and investigators in managing clinical trials, thus contributing to the cause of human health.